Meningitis
📧 Sign up to get email alerts when something new happens for Meningitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: A Sourcing Study to Collect Human Blood Samples From Healthy Adults [Phase 4]
Phase 4 trial update describing collection of human blood samples from healthy adults; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in Frequent Platelets Donors [Phase 4]
Phase 4 trial update assessing immunogenicity of a quadrivalent meningococcal conjugate vaccine in frequent platelet donors.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea [Phase 4]
Postmarketing surveillance study (Phase 4) evaluating Menactra in the Republic of Korea has completed.
-
FDA approval · 2022-03-18FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Cefepime hydrochloride and dextrose from B. Braun Medical Inc.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months [Phase 2]
A Phase 2 trial evaluated the immunogenicity and safety of a meningococcal ACYW135 polysaccharide conjugate vaccine in children aged 3 to 35…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-11-18FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved vancomycin hydrochloride as a generic drug under an Original Application from Slate Run Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort [NA]
A completed clinical trial focusing on precision diagnosis for acute infectious diseases in neuroinflammatory conditions (encephalitis and m…
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age [Phase 2]
Phase 2 trial investigating safety and immunogenicity of different formulations of MenACWY vaccine (GSK3536820A and Menveo) in healthy adole…
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Maternal Immunization With MenAfriVac™ [Phase 3]
Phase 3 clinical trial update for maternal immunization with MenAfriVac targeting meningitis/meningococcal disease.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine [Phase 3]
A Phase 3 trial update for a Group A and C meningococcal polysaccharide vaccine is reported, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine [Phase 3]
A Phase III trial update for a group A meningococcal polysaccharide vaccine; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Comparison of Two Meningococcal ACWY Conjugate Vaccines [Phase 2, Phase 3]
Phase 2/3 trial update comparing two meningococcal ACWY conjugate vaccines has completed.
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Hypovitaminosis D in Neurocritical Patients [Phase 2, Phase 3]
Phase 2/3 trial on vitamin D supplementation for neurocritical patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers [Phase 3]
Phase 3 trial update on the immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in toddlers has com…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years [Phase 3]
Phase 3 study of an investigational quadrivalent meningococcal conjugate vaccine in children aged 2 to 9 years has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a meningococcal conjugate vaccine given concomitantly with other vaccines in toddlers; …
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in healthy adolesc…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older [Phase 2]
Phase 2 trial of a quadrivalent meningococcal conjugate vaccine in adults 56 and older has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers [Phase 2]
Phase 2 trial update for a quadrivalent meningococcal tetanus protein conjugate vaccine in infants and toddlers; study completed with result…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine [Phase 3]
Phase 3 trial update on immunogenicity and safety of a booster dose for an investigational quadrivalent meningococcal conjugate vaccine; stu…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial updating immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in healthy toddlers; res…
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine [Phase 3]
Phase 3 trial update evaluating immune lot consistency, immunogenicity, and safety of an investigational quadrivalent meningococcal conjugat…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older [Phase 3]
Phase 3 trial assessing immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in adults 56 and older;…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years [Phase 2]
Phase 2 trial assessing immune interference from MenABCWY vaccine in healthy subjects aged 10-25; completed with posted results in 2020.